Skip to main content
. Author manuscript; available in PMC: 2012 Jun 14.
Published in final edited form as: Breast Cancer Res Treat. 2010 Dec 10;130(1):41–48. doi: 10.1007/s10549-010-1237-9

Table 1.

Summary of the incidence of the ERR-γ repeat in patient samples

Long allele non-carriers Long allele carriers Totals Incidence (%) Statistics (P value)
Baseline group
Healthy: no BC family hx n = 105 Healthy: all n = 174
Healthy volunteers
    No BC family hx 100 5 105 4.8 0.799
    BC family hx 64 5 69 8.2 0.520 0.514
    All healthy volunteers 164 10 174 5.7 0.791
Cancer patients
    Breast cancer 126 21 147 14.3* 0.020 0.013
    Other cancers 192 15 207 7.3 0.471 0.791
Total 482 46 528 8.7

Note: “BC family hx” refers to first degree (sister, daughter, or mother) or second degree (grandmother, aunt, niece, or granddaughter) family members with breast cancer. “Carriers” refer to persons in which the long allele (defined as at least 13 copies of the AAAG motif) is present. Asterisk indicates a statistically significant difference between the incidence of long allele carriers in breast cancer patients, compared to cancer-free volunteers, based on Fisher's exact test (P value = 0.0134, two-tailed comparison). A detailed list of patients and genotyping information is provided as Online Resource 1

BC breast cancer, hx history